These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27079619)

  • 1. Contractile effects of 3,4-methylenedioxymethamphetamine on the human internal mammary artery.
    Silva S; Carvalho F; Fernandes E; Antunes MJ; Cotrim MD
    Toxicol In Vitro; 2016 Aug; 34():187-193. PubMed ID: 27079619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.
    Fantegrossi WE; Godlewski T; Karabenick RL; Stephens JM; Ullrich T; Rice KC; Woods JH
    Psychopharmacology (Berl); 2003 Mar; 166(3):202-11. PubMed ID: 12563544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
    Kramer HK; Poblete JC; Azmitia EC
    Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans.
    Liechti ME; Saur MR; Gamma A; Hell D; Vollenweider FX
    Neuropsychopharmacology; 2000 Oct; 23(4):396-404. PubMed ID: 10989266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDMA modulates 5-HT
    Fonseca DA; Teixeira C; Carvalho F; Fernandes E; Antunes PE; Antunes MJ; Cotrim MD
    Toxicol In Vitro; 2019 Mar; 55():15-17. PubMed ID: 30448555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study.
    Murnane KS; Kimmel HL; Rice KC; Howell LL
    Horm Behav; 2012 Feb; 61(2):181-90. PubMed ID: 22197270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
    Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM
    Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.
    Durkin S; Prendergast A; Harkin A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1894-901. PubMed ID: 18824064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice.
    Renoir T; Païzanis E; El Yacoubi M; Saurini F; Hanoun N; Melfort M; Lesch KP; Hamon M; Lanfumey L
    Int J Neuropsychopharmacol; 2008 Dec; 11(8):1149-62. PubMed ID: 18611291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDMA induced dopamine release in vivo: role of endogenous serotonin.
    Koch S; Galloway MP
    J Neural Transm (Vienna); 1997; 104(2-3):135-46. PubMed ID: 9203077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
    Mechan AO; Esteban B; O'Shea E; Elliott JM; Colado MI; Green AR
    Br J Pharmacol; 2002 Jan; 135(1):170-80. PubMed ID: 11786492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat.
    Morley KC; Arnold JC; McGregor IS
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):648-57. PubMed ID: 15908091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies.
    Vegting Y; Reneman L; Booij J
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3473-501. PubMed ID: 27568200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.
    Rietjens SJ; Hondebrink L; Westerink RH; Meulenbelt J
    Crit Rev Toxicol; 2012 Nov; 42(10):854-76. PubMed ID: 23030234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.
    Urban NB; Girgis RR; Talbot PS; Kegeles LS; Xu X; Frankle WG; Hart CL; Slifstein M; Abi-Dargham A; Laruelle M
    Neuropsychopharmacology; 2012 May; 37(6):1465-73. PubMed ID: 22353758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated production of hydrogen peroxide in an in vitro model: the role of dopamine, the serotonin-reuptake transporter, and monoamine oxidase-B.
    Hrometz SL; Brown AW; Nichols DE; Sprague JE
    Neurosci Lett; 2004 Aug; 367(1):56-9. PubMed ID: 15308297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.
    Tancer M; Johanson CE
    Psychopharmacology (Berl); 2007 Jan; 189(4):565-73. PubMed ID: 17047932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical substrates of MDMA reward: effects of the inhibition of serotonin reuptake on the acquisition and reinstatement of MDMA-induced CPP.
    Roger-Sánchez C; Aguilar MA; Manzanedo C; Miñarro J; Rodríguez-Arias M
    Curr Pharm Des; 2013; 19(40):7050-64. PubMed ID: 23574442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus.
    Anneken JH; Gudelsky GA
    Neuropharmacology; 2012 Nov; 63(6):1022-7. PubMed ID: 22842073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of ecstasy synthesis byproducts with recombinant human monoamine transporters.
    Pifl C; Nagy G; Berényi S; Kattinger A; Reither H; Antus S
    J Pharmacol Exp Ther; 2005 Jul; 314(1):346-54. PubMed ID: 15831439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.